NDC 0338-0126 – Myxredlin
Insulin Human 1 [iU]/mL · Injection, Solution · Intravenous
Product NDC0338-0126
Product details
- Brand name
- Myxredlin
- Generic name
- Insulin human
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA208157
- Marketed since
- July 12, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Insulin
Active ingredients
- Insulin Human 1 [iU]/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0338-0126-12 | 12 CONTAINER in 1 CARTON (0338-0126-12) / 100 mL in 1 CONTAINER | Jul 12, 2019 |
Recalls mentioning this NDC
- D-0806-2026 Sep 9, 2026 · Class II
CGMP Deviations